1. Home
  2. MLYS vs TRST Comparison

MLYS vs TRST Comparison

Compare MLYS & TRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • TRST
  • Stock Information
  • Founded
  • MLYS 2019
  • TRST 1902
  • Country
  • MLYS United States
  • TRST United States
  • Employees
  • MLYS N/A
  • TRST N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • TRST Major Banks
  • Sector
  • MLYS Health Care
  • TRST Finance
  • Exchange
  • MLYS Nasdaq
  • TRST Nasdaq
  • Market Cap
  • MLYS 634.6M
  • TRST 612.5M
  • IPO Year
  • MLYS 2023
  • TRST N/A
  • Fundamental
  • Price
  • MLYS $9.77
  • TRST $32.51
  • Analyst Decision
  • MLYS Strong Buy
  • TRST
  • Analyst Count
  • MLYS 2
  • TRST 0
  • Target Price
  • MLYS $30.00
  • TRST N/A
  • AVG Volume (30 Days)
  • MLYS 266.6K
  • TRST 117.3K
  • Earning Date
  • MLYS 11-11-2024
  • TRST 01-21-2025
  • Dividend Yield
  • MLYS N/A
  • TRST 4.42%
  • EPS Growth
  • MLYS N/A
  • TRST N/A
  • EPS
  • MLYS N/A
  • TRST 2.48
  • Revenue
  • MLYS N/A
  • TRST $168,593,000.00
  • Revenue This Year
  • MLYS N/A
  • TRST N/A
  • Revenue Next Year
  • MLYS N/A
  • TRST $11.69
  • P/E Ratio
  • MLYS N/A
  • TRST $12.99
  • Revenue Growth
  • MLYS N/A
  • TRST N/A
  • 52 Week Low
  • MLYS $8.58
  • TRST $25.83
  • 52 Week High
  • MLYS $16.91
  • TRST $38.89
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 37.52
  • TRST 43.85
  • Support Level
  • MLYS $9.18
  • TRST $30.15
  • Resistance Level
  • MLYS $9.97
  • TRST $32.94
  • Average True Range (ATR)
  • MLYS 0.85
  • TRST 0.85
  • MACD
  • MLYS -0.25
  • TRST 0.10
  • Stochastic Oscillator
  • MLYS 24.53
  • TRST 61.46

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

About TRST TrustCo Bank Corp NY

Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The Company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey and Vermont.

Share on Social Networks: